Tapentadol Hydrochloride Tablet, Film Coated
Product Images NDC 73190-081

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tapentadol Hydrochloride (NDC 73190-081). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (081 01)

Packaging label for Tapentadol Tablets 50 mg, film-coated oral tablets by AvKARE. The label indicates the strength as 50 mg per tablet and a quantity of 100 tablets. It includes storage instructions, a barcode, and cautions that federal law prohibits transfer to anyone other than the prescribed patient. The manufacturer and distributor details are also present.*

FDA Label Image

1 (082 01)

The packaging label for Tapentadol Tablets 75 mg, film-coated tablets for oral use by AvKARE. The label states each tablet contains 75 mg of tapentadol, notes federal restrictions on transfer, and includes dosage storage instructions. The package holds 100 tablets, and it is marked Rx only. Manufacturer information and a barcode are also visible.*

FDA Label Image

1 (083 01)

Tapentadol Hydrochloride 100 mg film-coated tablets, oral dosage form, labeled by AvKARE. The label indicates 100 tablets per package. It includes a cautionary statement about federal law, dosage instructions referencing package insert, storage conditions, and manufacturer details listing AvKARE and MSN Pharmaceuticals. The label contains barcode and regulatory information.*

FDA Label Image

Tapentadol-tabs-figure-1 (Tapentadol Tabs Figure 1)

A line graph showing the percent of patients improved over time based on percent improvement in pain from baseline at hour 48. The graph compares placebo and Tapentadol tablets at strengths of 50 mg, 75 mg, and 100 mg with separate lines for each group, illustrating differences in patient improvement percentages.*

FDA Label Image

Tapentadol-tabs-figure-2 (Tapentadol Tabs Figure 2)

A line graph showing the percent of patients improved versus percent improvement in pain from baseline on Day 5. It compares three groups: placebo, Tapentadol 50 mg, and Tapentadol 75 mg. The graph tracks patient improvement across increasing pain reduction percentages, with Tapentadol groups showing higher improvement than placebo.*

FDA Label Image

Tapentadol-tabs-structure (Tapentadol Tabs Structure)

Chemical structure of tapentadol hydrochloride showing its molecular arrangement including a phenol group, methyl groups, and an attached hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.